ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,776Medicare Part D Prescriptions Filled, Including Refills

Rank: 225 out of 3734

$915K Total Retail Price of All Prescriptions

Rank: 139 out of 3734

606 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 12,171 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 659 567 1 1
LISINOPRIL 514 424 2 3
METOPROLOL TARTRATE 438 377 3 6
OMEPRAZOLE 431 347 4 4
AMLODIPINE BESYLATE 408 360 5 5
LEVOTHYROXINE SODIUM 394 381 6 2
CAPTOPRIL 300 293 7 256
ATORVASTATIN CALCIUM 248 239 8 11
WARFARIN SODIUM 235 188 9 10
METFORMIN HCL 232 194 10 8
HYDROCHLOROTHIAZIDE 229 206 11 9
FENOFIBRATE 208 167 12 81
CELEBREX 206 191 13 69
POTASSIUM CHLORIDE 206 198 13 19
FUROSEMIDE 197 167 15 7
NEXIUM 173 157 16 36
GLYBURIDE 170 170 R 17 64
DILTIAZEM 24HR ER 160 119 18 86
LOSARTAN POTASSIUM 159 141 19 21
DONEPEZIL HCL 154 149 20 25
GABAPENTIN 152 123 21 17
TRIAMTERENE-HCTZ 146 136 22 73
HYDROCODONE-ACETAMINOPHEN 136 116 S3 23 12
SERTRALINE HCL 136 122 23 18
CARVEDILOL 128 124 25 30
ZOLPIDEM TARTRATE 127 103 26 24
ALENDRONATE SODIUM 127 121 26 26
PLAVIX 125 121 28 39
FENTANYL 116 109 S2 29 65
CLOPIDOGREL 114 107 30 23
DILTIAZEM 24HR CD 107 100 31 97
ATENOLOL 104 80 32 13
DIGOXIN 100 99 33 43
VERAPAMIL ER 99 90 34 96
NAMENDA 99 99 34 44
TAMSULOSIN HCL 97 93 36 29
CYMBALTA 96 78 37 67
SINGULAIR 95 79 38 95
DIOVAN 94 92 39 31
ZETIA 90 86 40 55
CITALOPRAM HBR 89 72 41 16
OXYCODONE-ACETAMINOPHEN 87 81 S2 42 51
PANTOPRAZOLE SODIUM 84 83 43 22
SYNTHROID 82 80 44 47
PRADAXA 80 80 45 205
ALLOPURINOL 77 71 46 33
LANTUS 77 77 46 54
QUINAPRIL HCL 73 66 48 74
CLONIDINE HCL 70 67 49 79
KLOR-CON M10 70 67 49 115
GLYBURIDE-METFORMIN HCL 66 66 R 51 154
ACTOS 64 59 52 110
TRAMADOL HCL 62 56 53 20
PROPRANOLOL HCL 62 61 53 126
BUMETANIDE 62 42 53 78
PREDNISONE 59 56 56 42
VESICARE 58 45 57 157
BYSTOLIC 58 54 57 148
LYRICA 58 43 57 124
AMOX TR-POTASSIUM CLAVULANATE 57 46 60 164
MONTELUKAST SODIUM 57 52 60 175
SPIRIVA 55 47 62 40
TEKTURNA 53 52 63 376
METOCLOPRAMIDE HCL 52 34 64 158
SPIRONOLACTONE 51 40 65 80
KLOR-CON M20 50 45 66 48
GUANFACINE HCL 50 39 R 66 403
POLYETHYLENE GLYCOL 3350 50 46 66 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.